ScholarIQanswers from OpenAlex & ORCID
Fedja A. Rochling
ResearcherPublications, citations & collaboration network
Fedja A. Rochling is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Fedja A. Rochling have?
ScholarIQindexed works
Fedja A. Rochling has 85 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Fedja A. Rochling have?
ScholarIQcitation count
Fedja A. Rochling has 3,491 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Fedja A. Rochling?
ScholarIQh-index
Fedja A. Rochling has an h-index of 17 in OpenAlex.
What is the i10-index of Fedja A. Rochling?
ScholarIQi10-index
Fedja A. Rochling has an i10-index of 24 in OpenAlex.
What is the ORCID of Fedja A. Rochling?
ScholarIQorcid
The ORCID for Fedja A. Rochling is on the source record.
What is the OpenAlex record for Fedja A. Rochling?
ScholarIQopenalex
The OpenAlex for Fedja A. Rochling is on the source record.
What are the most-cited papers on Fedja A. Rochling?
ScholarIQmost cited works
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro, Josep M. Llovet, Rosalba Miceli, Sherrie Bhoori, Marcello Schiavo, Luigi Mariani, Tiziana Camerini, Sasan Roayaie, Myron Schwartz, Gian Luca Grazi, René Adam, P. Neuhaus, Mauro Salizzoni, Jordi Bruix, Alejandro Forner, Luciano De Carlis, Umberto Cillo, Andrew K. Burroughs, Roberto Troisi, Massimo Rossi, Giorgio Enrico Gerunda, Jan Lerut, Jacques Belghiti, I. Boin, Jean Gugenheim, Fedja A. Rochling, Bart van Hoek, Pietro Majno
Acetaminophen Toxicity in an Urban County Hospital
Frank Vinholt Schiødt, Fedja A. Rochling, Donna L. Casey, William M. Lee
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones, Pol Boudes, Mark G. Swain, Christopher L. Bowlus, Michael Galambos, Bruce R. Bacon, Yvonne Döerffel, Norman Gitlin, Stuart C. Gordon, Joseph A. Odin, David Sheridan, M A Wörns, Virginia Clark, Linsey Corless, Heinz Hartmann, Mark Jonas, Andreas E. Kremer, George Mells, Peter Buggisch, B. Freilich, Cynthia Levy, John M. Vierling, David Bernstein, Marek Hartleb, Ewa Janczewska, Fedja A. Rochling, Hemant Shah, Mitchell L. Shiffman, John H. Smith, Yun‐Jung Choi, Alexandra Steinberg, Mónika Varga, Harinder Chera, Robert L. Martin, Charles A. McWherter, Gideon M. Hirschfield
Current Management of Short Bowel Syndrome
Jon S. Thompson, Fedja A. Rochling, Rebecca A. Weseman, David F. Mercer
Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis
Marlyn J. Mayo, Elizabeth J. Carey, Helen T. Smith, Andrea R. Mospan, Megan McLaughlin, April Thompson, Heather Morris, Robert Sandefur, W. Ray Kim, Christopher L. Bowlus, the TARGET-PBC Investigators, Victor Ankoma‐Sey, David I. Bernstein, Brian B. Borg, Christopher L. Bowlus, Robert Brown, Elizabeth J. Carey, Virginia Clark, Jama M. Darling, Jonathan A. Dranoff, Hany Elbeshbeshy, Lisa Forman, Aparna Goel, James Hanje, Stephen A. Harrison, Sujit Janardhan, Randhir Jesudoss, David Kim, Lindsay Y. King, Charles Landis, Cynthia Levy, Anna Lok, Michael R. Lucey, V LUKETIC, Richard Manch, W. van der Mark, Marlyn J. Mayo, Edward Mena, Apurva A. Modi, Gautham P. Reddy, K. Rajender Reddy, Fedja A. Rochling, Sergio Rojter, Raymond A. Rubin, Mark Russo, Mitchell Shiffman, Marina G. Silveira, Carmen Stanca, Paul J. Thuluvath, Elizabeth C. Verna, Laurence Weiss, Cynthia Levy